Dr. Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product. As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), the Hyderabad-based drug firm is voluntarily recalling 1,752 bottles (1,000 counts) of 40 mg Esomeprazole Magnesium delayed-release capsules in the US.
The ongoing Class III recall is on account of Discolouration and because the product contains brown pellets. As per the US health regulator, a class III recall is initiated in a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. The recalled product lot has been manufactured at company’s Bachupally manufacturing facility in Telangana and is being recalled by the company's US-based arm.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: